Home / Pharmaceuticals / Photopheresis Market By Product Type (Closed System and Open System), By Therapeutic Area Type (Cutaneous T-cell lymphoma, Solid Organ Transplant Rejections, Autoimmune Diseases, and Graft Versus Host Disease ) - Growth, Future Prospects, and Competitive Analysis, 2017 -2025

Photopheresis Market By Product Type (Closed System and Open System), By Therapeutic Area Type (Cutaneous T-cell lymphoma, Solid Organ Transplant Rejections, Autoimmune Diseases, and Graft Versus Host Disease ) - Growth, Future Prospects, and Competitive Analysis, 2017 -2025

Published: Oct 2017 | Report Code: 58735-10-17

The report titled “Photopheresis Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall photopheresis market along with the market size and estimates for the duration 2015 to 2025. The said research study cover in-depth analysis of photopheresis market segments based on type of products, therapeutic area, and different geographies further segmented by countries.

For the purpose of this study, the global photopheresis treatment market is segmented on the basis of product type into open system, and close system. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

For the purpose of this study, the global photopheresis market is segmented on the basis of therapeutic area type into cutaneous T-cell lymphoma, solid organ transplant rejections, autoimmune diseases, and graft versus host disease. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The geographical segmentation of photopheresis market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.

The photopheresis market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, and Mallinckrodt Pharmaceuticals among others.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Photopheresis Market Portraiture
2.2. Global Photopheresis Market, By Product Type, 2016 (US$ Mn)
2.3. Global Photopheresis Market, By Therapeutic Area Type, 2016 (US$ Mn)
2.4. Global Photopheresis Market, by Geography, 2016 Vs 2025 (Value %)

Chapter 3. Photopheresis Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Photopheresis: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Photopheresis Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Photopheresis Market, by Product Type
4.2. Closed System
4.3. Open System

Chapter 5. Global Photopheresis Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Cutaneous T-cell lymphoma
5.3. Solid Organ Transplant Rejections
5.4. Autoimmune Diseases
5.5. Graft Versus Host Disease

Chapter 6. Global Photopheresis Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Photopheresis Market Analysis, 2015 – 2025
6.2.1. North America Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
6.2.3. North America Photopheresis Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Photopheresis Market Analysis, 2015 – 2025
6.3.1. Europe Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
6.3.3. Europe Photopheresis Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Spain
6.3.3.5. Italy
6.3.3.6. Rest of Europe
6.4. Asia Pacific Photopheresis Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Photopheresis Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Photopheresis Market Analysis, 2015 – 2025
6.5.1. Latin America Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Photopheresis Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Photopheresis Market Analysis, 2015 – 2025
6.6.1. MEA Photopheresis Market, by Product Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
6.6.3. MEA Photopheresis Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. UAE
6.6.3.2. Saudi Arabia
6.6.3.3. South Africa
6.6.3.4. Rest of MEA

Chapter 7. Company Profiles
7.1. Haemonetics Corporation
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Fresenius Kabi AG
7.3. Macopharma
7.4. Mallinckrodt Pharmaceuticals
7.5. Med Tech Solutions GmbH
7.6. Terumo Corporation

List of Tables

TABLE 1 Global Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Photopheresis Market, By Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Photopheresis Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Photopheresis Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Photopheresis Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Photopheresis Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East And Africa Photopheresis Market, By Product Type, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East And Africa Photopheresis Market, By Therapeutic Area Type, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East And Africa Photopheresis Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 19 Haemonetics Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Fresenius Kabi AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Macopharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Med Tech Solutions GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List of Figures

FIG. 1 Photopheresis: Market Segmentation
FIG. 2 Global Photopheresis Market Share, By Product Type, 2016 (US$ Mn)
FIG. 3 Global Photopheresis Market Share, By Therapeutic Area Type, 2016 (US$ Mn)
FIG. 4 Global Photopheresis Market, by Geography, 2016 Vs 2025 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2016
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Closed System Photopheresis Products Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Open System Photopheresis Products Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Cutaneous T-cell lymphoma Treatment Market by Photopheresis, 2015 – 2025 (US$ Mn)
FIG. 10 Global Solid Organ Transplant Rejections Treatment Market by Photopheresis, 2015 – 2025 (US$ Mn)
FIG. 11 Global Autoimmune Diseases Treatment Market by Photopheresis, 2015 – 2025 (US$ Mn)
FIG. 12 Global Graft Versus Host Disease Treatment Market by Photopheresis, 2015 – 2025 (US$ Mn)
FIG. 13 U.S. Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 14 Canada Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 15 U.K. Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 16 Germany Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 17 France Photopheresis Market, 2015-2025 (US$ Mn)
FIG. 18 Spain Photopheresis Market, 2015-2025 (US$ Mn)
FIG. 19 Italy Photopheresis Market, 2015-2025 (US$ Mn)
FIG. 20 Rest Of Europe Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 21 Japan Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 22 China Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 23 India Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 24 Rest Of Asia Pacific Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 25 Brazil Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 26 Mexico Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest Of Latin America Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 28 UAE Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 29 Saudi Arabia Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 30 South Africa Photopheresis Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest Of Middle East And Africa Photopheresis Market, 2015 – 2025 (US$ Mn)

Based on the type of product, the global photopheresis market is segmented as follows:

  • Closed System
  • Open System

In year 2016, closed system was observed as the largest segment in photopheresis market due to key market drivers such as technologically advanced than open systems, increasing preference for these systems from medical practitioners, and covers all major chronic diseases. According to market experts, in a closed ECP system which is a one step method, the cell separation, drug photoactivation, and re-infusion stages are fully integrated, automated and the components are validated for use together, tested and approved for use. Hence, with these advantages closed systems are always treatment of choice by medical practitioners.

Photopheresis Market

 

Based on the type of therapeutic area, the global photopheresis market is segmented as follows:

  • Cutaneous T-cell lymphoma
  • Solid Organ Transplant Rejections
  • Graft Versus Host Disease
  • Autoimmune Diseases

 

Photopheresis Market

In 2016, cutaneous T-cell lymphoma was observed as the largest segment in global photopheresis market due to key driving factors such as rising prevalence of cutaneous T-cell lymphoma, increasing awareness associated with early disease diagnosis, supportive reimbursement environment, and continuous development in the field of research and development. During the forecast period 2017 – 2025, autoimmune diseases was observed as the fastest growing segment in photopheresis market due to key factors such as rising awareness against the most prevalent autoimmune diseases, market introduction of novel diagnostic technology, and incessant research and development activities carried out by market players.

For the purpose of this study, the global photopheresis market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Photopheresis Market
 

In base year 2016, North America accounted for the largest share in global photopheresis market due to key driving factors such as rising prevalence and awareness associated with orphan diseases, rising awareness associated with early diagnosis and treatment of orphan diseases, supportive reimbursement policies coupled with constant awareness campaigns organized by governmental and non-governmental organizations, and incessant developments in the field of research and development. According to Cutaneous Lymphoma Foundation, in 2015 the prevalence of cutaneous T-cell lymphoma (CTCL) was 16,000 to 20,000 in the US. During the forecast period 2017 – 2025, Asia Pacific was observed as the fastest growing region due to key driving factors such as increasing awareness associated with orphan diseases, patient education campaigns carried out by governmental and non-governmental organizations, developing healthcare infrastructure, and mounting accessibility of modern treatments in developing countries such as China, India, Thailand, and Indonesia.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients